Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
dexamethasone + gentamicin + vitamin B12 + procaine
- Development stage
- Unknown
- Lead developer
- Merck
- Modality
- Small Molecules
- Administration
- Intramuscular, Local Injection, Perineural Injection
01
Overview
A combination drug containing dexamethasone (a corticosteroid), gentamicin (an aminoglycoside antibiotic), vitamin B12 (cyanocobalamin), and procaine (a local anesthetic). Dexamethasone provides anti-inflammatory effects, gentamicin offers antimicrobial activity, vitamin B12 supports nerve function and repair, and procaine contributes local anesthetic properties. This combination may be used for conditions involving inflammation, infection, and neuropathic pain.
02
Targets
Bacterial RibosomeGR (Glucocorticoid receptor)NaV (Voltage-gated sodium channels)
Beyond the preview
Go deeper on dexamethasone + gentamicin + vitamin B12 + procaine.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on dexamethasone + gentamicin + vitamin B12 + procaine.